Inventor · disambiguated record
Theresa Rosario-Jansen
Also filed as: ROSARIO-JANSEN THERESA
13 granted patents·2 pending applications·253 citations·filing 1989–2024
93Inventor score
Files withHORIZON THERAPEUTICS USA INC5PROCTER & GAMBLE3HORIZON PHARMA RHEUMATOLOGY LLC2ROSARIO-JANSEN THERESA2WATSON PHARMACEUTICALS INC2
Top patents by PatentIndex Score
15 records- 0196US11639927B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2020·Granted May 2, 2023·7 cites·9 claims
- 0296US11598767B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2022·Granted Mar 7, 2023·5 cites·4 claims
- 0395US10823727B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON PHARMA RHEUMATOLOGY LLC·Filed 2018·Granted Nov 3, 2020·12 cites·3 claims
- 0495US10139399B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapyHORIZON PHARMA RHEUMATOLOGY LLC·Filed 2018·Granted Nov 27, 2018·11 cites·6 claims
- 0594US9377454B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyROSARIO-JANSEN THERESA·Filed 2010·Granted Jun 28, 2016·33 cites·6 claims
- 0694US6583129B1Administration of non-oral androgenic steroids to womenWATSON PHARMACEUTICALS INC·Filed 2000·Granted Jun 24, 2003·99 cites·30 claims
- 0791US2025231181A1Methods and kits for predicting infusion reaction risk and antibody mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2024·Application pending·0 cites
- 0890US12188927B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2024·Granted Jan 7, 2025·0 cites·17 claims
- 0986US7186706B2Administration of non-oral androgenic steroids to womenWATSON PHARMACEUTICALS INC·Filed 2002·Granted Mar 6, 2007·25 cites·18 claims
- 1085US11982670B2Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyHORIZON THERAPEUTICS USA INC·Filed 2023·Granted May 14, 2024·0 cites·9 claims
- 1182US4954635AProcess for preparing quaternized imidazoline fabric conditioning compoundsPROCTER & GAMBLE·Filed 1989·Granted Sep 4, 1990·22 cites·17 claims
- 1274US8551516B2Administration of non-oral androgenic steroids to womenROSARIO-JANSEN THERESA·Filed 2007·Granted Oct 8, 2013·2 cites·27 claims
- 1374US5476876ADi-tert-butylphenol compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1994·Granted Dec 19, 1995·13 cites·16 claims
- 1463US5116520AFabric softening and anti-static compositions containing a quaternized di-substituted imidazoline ester fabric softening compound with a nonionic fabric softening compoundPROCTER & GAMBLE·Filed 1990·Granted May 26, 1992·24 cites·22 claims
- 1563US2016377604A1Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapyCREALTA PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Theresa Rosario-Jansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →